crystallization communications
Crystallization and preliminary X-ray Pseudomonas sp. strain ADP
of the amidase domain of allophanate hydrolase fromaEcosystem Sciences, CSIRO, GPO Box 1700, Canberra, ACT 2601, Australia, and bMaterials, Science and Engineering, CSIRO, 343 Royal Parade, Parkville, VIC 3052, Australia
*Correspondence e-mail: colin.scott@csiro.au
The allophanate hydrolase from Pseudomonas sp. strain ADP was expressed and purified, and a tryptic digest fragment was subsequently identified, expressed and purified. This 50 kDa construct retained amidase activity and was crystallized. The crystals diffracted to 2.5 Å resolution and adopted P21, with unit-cell parameters a = 82.4, b = 179.2, c = 112.6 Å, β = 106.6°.
Keywords: AtzF; allphanate hydrolase; amidase domain; Pseudomonas sp. strain ADP.
1. Introduction
Allophanate hydrolase (EC 3.5.1.54) from Pseudomonas sp. strain ADP (AtzF) is a member of the amidase family of enzymes that possess a conserved serine- and glycine-rich motif, the so-called `amidase signature' sequence (Shapir et al., 2005). The amidases are serine that catalyze the hydrolysis of an amide group to a carboxylic acid with the concomitant release of ammonia. These enzymes adopt a classic α-β-α fold and possess a Ser-cisSer-Lys catalytic triad that is conserved throughout the family (Shin et al., 2002). The catalytic serine in AtzF (Ser189) has been identified experimentally (Shapir et al., 2005). AtzF contains 605 amino acids with an estimated molecular weight of 64 kDa, while the estimated native molecular weight has been shown to be approximately 260 kDa (Shapir et al., 2005), suggesting that the native functional enzyme is a tetramer. The substrate range of allophanate hydrolase is quite narrow, and to date allophanate, malonamate and biuret are the only known substrates of this enzyme (Shapir et al., 2005, 2006). The native substrate of AtzF, allophanate, is generated by two biological processes: cyanuric acid mineralization and urea decomposition (Shapir et al., 2005; Kanamori et al., 2004).
In most ureolytic organisms, the nickel-containing et al., 1969), which spontaneously decays into ammonia and carbon dioxide (Carter et al., 2009). However, there is an alternate urea metabolism pathway (Fig. 1), the urea carboxylate pathway, which is used by some algae and fungi (Strope et al., 2011). In this pathway, urea carboxylase first catalyzes the ATP-dependent carboxylation of urea to form allophanate, which is subsequently deaminated by allophanate hydrolase, leading to the production of ammonia and carbon dioxide (Kanamori et al., 2004; Maitz et al., 1982; Roon & Levenberg, 1972).
urease (EC 3.5.1.5) provides a single-step hydrolysis of urea that yields ammonia and carbamate (BlakeleyAllophanate hydrolase also participates in the cyanuric acid mineralization pathway (Fig. 1), in which the cyanuric acid ring is hydrolytically opened by cyanuric acid hydrolase (AtzD or TrzD; EC 3.5.2.15) forming the unstable metabolite carboxybiuret, which spontaneously decarboxylates to form biuret (Peat et al., 2013; Udiković-Kolić et al., 2012). Allophanate is produced from biuret by AtzE (biuret hydrolase; EC 3.5.1.84) via a single deamination (Martinez et al., 2001). Hydrolysis of allophanate is then carried out by allophanate hydrolase (Martinez et al., 2001).
Here, we report the expression, purification, crystallization and initial X-ray Pseudomonas sp. strain ADP.
of the allophanate hydrolase (AtzF) from2. Materials and methods
2.1. Cloning
The atzF gene was obtained from GenScript (New Jersey, USA); the coding sequence used was identical to that described by Martinez et al. (2001) (accession No. U66917) and was provided as an NdeI/BamHI insert in pUC57 (supplied by GenScript; Table 1). The NdeI/BamHI restriction fragment containing the atzF gene was subcloned into the NdeI and BamHI sites of pETCC2 (Peat et al., 2013).
For the construction of the gene encoding C-terminally truncated AtzF (AtzF467), primers were designed to amplify the region corresponding to the first 1404 bp of the atzF gene (AtzF Rev Trunc; Table 1). Phusion DNA polymerase and dNTPs were purchased from New England Biolabs (Ipswich, USA). AtzF Fwd A and AtzF Rev Trunc primers (Table 1) were used to amplify the targeted region of atzF. The reaction conditions for PCR were 1× Phusion HF Buffer, 2 pg pETCC2-atzF DNA template, 0.5 µM primers, 200 µM dNTPs and one unit of Phusion DNA polymerase in a total reaction volume of 50 µl. The cycle conditions for the PCR reaction were a 30 s step at 98°C followed by annealing at 53°C for 20 s and then extension for 120 s at 72°C for 30 cycles. The amplicon was separated on 0.6% agarose gel by to confirm the size of the amplicon. The DNA band was excised from the gel and was purified using a NucleoSpin Gel and a PCR Clean-up kit (Macherey-Nagel). The purified DNA was double digested with BamHI-HF and NdeI enzymes (NEB) before it was cloned into pETCC2 vector at BamHI and NdeI restriction sites using T4 DNA ligase (NEB) as per the manufacturer's instructions.
2.2. Expression and purification of AtzF and AtzF467
pETCC2 derivatives containing either atzF or atzF467 were used to transform electrocompetent Escherichia coli BL21 (λDE3) cells (Invitrogen) and were grown at 310 K on Luria–Bertani (LB), Miller (Miller, 1972) agar plates supplemented with 100 µg ml−1 ampicillin. Overnight starter cultures of 50 ml were inoculated with 4–5 colonies. The overnight cultures were diluted 1:20 into 950 ml LB, Miller medium and shaken at 310 K and 200 rev min−1 until an OD600 of 0.6–0.8 was attained. Protein expression was initiated by the addition of 100 µM isopropyl β-D-1-thiogalactopyranoside (IPTG). The induced cultures were kept at 310 K overnight whilst shaking at 200 rev min−1.
The cells were harvested by centrifugation at 4000g for 10 min in an Avanti J-E centrifuge (Beckman Coulter, Indianapolis, USA) and then resuspended in lysis buffer (50 mM HEPES, 100 mM NaCl pH 7.5 for AtzF and 50 mM Tris, 100 mM NaCl pH 7.5 for AtzF467) and lysed by passage through an Avestin C3 homogenizer three times at 124 MPa. Insoluble cellular debris was removed by centrifugation at 21 000g using an Avanti J-E centrifuge.
Wild-type AtzF was purified from the soluble cell-free extract in three steps: His-tag M imidazole in 50 mM HEPES, 100 mM NaCl pH 7.5, using a HiTrap Q HP column (GE Healthcare Life Sciences, Uppsala, Sweden) and a gradient of 100–1000 mM NaCl in 50 mM HEPES pH 7.5, and finally using a 130 ml column packed with Superdex 200 prep-grade resin (GE Healthcare Life Sciences) with a buffer comprised of 50 mM HEPES, 100 mM NaCl pH 7.5. 20 column volumes of buffer were used to achieve the gradients used for the Ni–NTA Superflow cartridge and HiTrap Q HP purification steps. The protein was concentrated in an Amicon Ultra-15 Centrifugal Filter Unit with an Ultracel-30 membrane (Millipore, Carrigtwohill, Ireland) to 5 mg ml−1 and snap-frozen in liquid nitrogen in 100 ml aliquots. The final purity was estimated to be 98% from a Coomassie-stained gel, and typical yields were 18–20 mg purified protein from 1 l LB medium.
using an Ni–NTA Superflow cartridge (Qiagen, Maryland, USA) with a gradient of 0–300 mAtzF467 was purified from soluble cell-free extract in two steps: binding to an Ni–NTA column followed by a wash step with 50 mM Tris, 100 mM NaCl pH 7.5 buffer and then by two wash steps with 10 mM imidazole and 20 mM imidazole in 50 mM Tris, 100 mM NaCl pH 7.5 buffer. Finally, the protein was eluted with 250 mM imidazole. The protein was further purified by using the same column as used for AtzF but in 50 mM Tris, 100 mM NaCl pH 7.5 buffer. The final purity was estimated to be 98% from a Coomassie-stained gel, and typical yields were 70–75 mg purified protein from 1 l LB medium. All protein chromatographic work was conducted using an ÄKTApurifier UPC 10 (GE Healthcare Life Sciences). The purified protein was concentrated to about 5 mg ml−1 and snap-frozen (using liquid nitrogen) in 50–100 µl aliquots.
Both purified AtzF and AtzF467 include 20-amino-acid N-terminal extensions that include a thrombin cleavage site and a hexahistidine tag (Table 1).
2.3. Proteolysis and N-terminal sequencing
Limited proteolysis of full-length AtzF (0.8 mg ml−1) was carried out with 0.04 mg ml−1 trypsin (MP Biomedicals, Australia) at 293 K for 48 h. Tryptic fragments were separated by SDS–PAGE (Shapiro et al., 1967) using Tris–HEPES 10–20% precast gels (NuSep; Fig. 2). N-terminal sequencing of the proteolytic products was used to identify the position of the proteolysis site (Australian Proteome Analysis Facility, Sydney, Australia).
2.4. Activity test for full-length AtzF and AtzF467
Biuret (Sigma–Aldrich, St Louis, USA) was used as a substrate to determine the activity of the wild-type and truncated enzymes. The hydrolytic production of ammonia from biuret by AtzF and truncated AtzF was measured using an ammonia assay kit (Sigma–Aldrich). Briefly, L-glutamate dehydrogenase (GDH) reductively aminates α-ketoglutaric acid in an NADPH-dependent reaction (Bergmeyer, 1990). The consumption of NADPH results in a decrease in the UV absorbance at 340 nm. A SpectraMax M2 spectrophotometer (Molecular Devices, California, USA) was used to follow the decrease in absorbance in this assay. The assay was performed in 280 mM TAPS buffer pH 9; the concentrations and components of the reaction were 10 µg BSA, 0.5 mM NADPH, 10 mM α-ketoglutaric acid, 50 mM biuret, 191 pmol AtzF or AtzF467, 0.875 U GDH.
An ammonia standard (150 µM) provided with the kit was used as a positive control. Enzyme-free negative controls contained 50 mM biuret in addition to the kit reagents and a substrate-free control contained 191 pmol AtzF or AtzF467 along with the kit reagents.
2.5. Stability analysis
Heat-denaturation curves of the full-length AtzF protein, along with AtzF467, were generated using differential scanning fluorimetry. The two samples were tested in a suite of different buffers and pHs in triplicate (`buffer screen 9'; Seabrook & Newman, 2013). The assay was performed in a CFX96 RT-PCR machine (Bio-Rad) with 19.6 µl of each screening condition, 300 nl protein at 5–6 mg ml−1 and 300 nl of a 1:10 (aqueous) dilution of SYPRO Orange dye (Sigma). Both proteins displayed curves indicative of a well folded protein: AtzF in the buffer used in the final step (50 mM HEPES, 100 mM NaCl pH 7.5) displayed a Tm of 50.4°C and AtzF467 in 50 mM Tris pH 7.5, 100 mM NaCl displayed a melting temperature 2°C higher (Fig. 3)
2.6. Crystallization
All crystallization experiments were performed in 96-well SD-2 plates (IDEX, USA) against a 50 µl reservoir. Most often, the droplets consisted of 150 nl concentrated protein combined with 150 nl reservoir solution. Either a Phoenix (Art Robbins Instruments, USA) or a Mosquito (TTP LabTech, UK) robot was used to place the crystallization drops. Initial screening experiments with two commercial screens (JCSG+ and PACT; Newman et al., 2005) and a 96-condition pH/salt gradient (PS gradient) screen at two temperatures, 20 and 8°C, showed no hits. The screening was extended to an 8 × 96 condition (768-condition) in-house screen (C3 screen; details of this and the PS gradient screen are available at https://c6.csiro.au ), set up both in a conventional manner (droplets against a reservoir of crystallant solution) and against a reservoir of 1.5 M NaCl at 20°C. After 35 d, well shaped hexagonal crystals were observed in a drop equilibrated against 4 M sodium formate (Fig. 4). These crystals showed poor diffraction (6.5 Å maximum resolution) on the MX2 (microfocus) beamline of the Australian Synchrotron. These crystals could not be reproduced, even with seeding. In situ proteolysis screening experiments were set up using either trypsin or chymotrypsin (1:1000 ratio of protease:AtzF) in the JCSG+, PACT and PS gradient screens at 20°C, and after a month some indications of crystallinity were observed in several ammonium sulfate-containing conditions of the PS gradient screen. The C3_6 screen, which focuses on ammonium sufate-containing conditions, was set up at both 8 and 20°C with trypsin or chymotrypsin-treated protein, and an intergrown plate-shaped crystal was observed with the trypsin-treated protein in a condition consisting of 1 M ammonium sulfate, 1 M lithium sulfate, 0.1 M Tris chloride pH 8.5. Trypsin digests of the full-length protein, followed by mass-spectrometric analysis, revealed one major digestion site, resulting in a large N-terminal domain and a smaller C-terminal domain of molecular weights 48 and 14 kDa, respectively. Enzyme assays showed that the larger domain retained the amidase activity. An N-terminal His-tagged construct of the larger domain was produced, concentrated to 5.5 mg ml−1 and set up against the JCSG+, PACT and PS gradient screens as above, with droplets consisting of 200 nl protein and 200 nl crystallant. The protein crystallized as intergrown plates from PACT condition B9 [0.2 M lithium chloride, 0.1 M MES pH 6.5, 20%(w/v) PEG 6K]. Crystals from this droplet were crushed and used to microseed further screening experiments, using in particular PEG-based screens, including PEG/Ion HT from Hampton Research. With seeding, the protein crystallized readily, producing a number of hits in PEG conditions. Crystals with a more robust morphology were found after two weeks in droplets from the PEG/Ion screen containing Tacsimate (Tacsimate is a mixture of organic acids produced by Hampton Research, which comprises 1.8305 M malonic acid, 0.25 M triammonium citrate, 0.12 M succinic acid, 0.3 M DL-malic acid, 0.4 M sodium acetate, 0.5 M sodium formate and 0.16 M diammonium tartrate) at pH 5 or lower and 12–16%(w/v) PEG 3350. Optimization around these conditions and microseeding with the improved crystals led to the production of optimized crystals in conditions consisting of 11–14%(w/v) PEG 3350, 2% Tacsimate pH 5 at 293 K (Fig. 4).
2.7. X-ray diffraction data collection
Optimized crystals were tested in a number of cryoprotectants on the MX2 beamline of the Australian Synchrotron. A crystal grown against a reservoir consisting of 11%(w/v) PEG 3350, 2% Tacsimate pH 5 was briefly introduced to a cryoprotectant consisting of 10% ethylene glycol, 10% glycerol, 80% reservoir solution and then flash-cooled in a stream of cold N2 at the beamline. 360° of data (2 s exposure, 1° oscillation, wavelength of 0.9529 Å) were collected.
Data were indexed with XDS (Kabsch, 2010) and scaled using SCALA (Evans, 2006). using Phaser (McCoy et al., 2007) with PDB entry 2dqn (Nakamura et al., 2006) as a search model revealed a clear solution with a log-likelihood gain of 757.
3. Results and discussion
AtzF from Pseudomonas sp. strain ADP was expressed heterologously in E. coli and purified to apparent The yield of purified AtzF varied from 18 to 20 mg per litre of culture. The of the purified enzyme was determined to be 15.4 µmol min−1 pmol−1 using 50 mM biuret as a substrate. (Fig. 2) suggested that native AtzF was a homohexamer (∼360 kDa), rather than a tetramer (∼240 kDa) as suggested elsewhere (Shapir et al., 2005).
Thermal stability studies of AtzF showed that the transition from the native to the unfolded state follows a Tm of 48.3°C (Fig. 3); however, the protein was recalcitrant to crystallization (Fig. 4). In situ proteolysis crystallization trials resulted in the formation of needle-shaped crystallites (Fig. 4), which suggested that a fragment of the full-length enzyme produced by a tryptic digest may be more amenable to structural studies.
with aScaled-up tryptic proteolysis of the full-length protein produced two major fragments of approximately 48 and 14 kDa (Fig. 2). N-terminal sequencing of the smaller 14 kDa band identified the location of the tryptic digestion as Lys467, whereas for the 48 kDa band the location of the tryptic cut was arginine at position 13. This suggested that larger 48 kDa fragment was the N-terminal fragment and the 14 kDa fragment was the C-terminal fragment. Moreover, the 48 kDa fragment was predicted by pBLAST to contain the entire amidase domain (i.e. the domain that is likely to be responsible for allophanate deamination).
A gene encoding the first 467 amino acids of AtzF (N-terminally histidine-tagged) was expressed and the product was purified to apparent 467) yielded 3.5–3.8 times more purified protein per litre of medium compared with full-length AtzF (i.e. 72–75 mg AtzF467 per litre). The of AtzF467 for biuret was 17.6 µmol min−1 pmol−1 (using 50 mM biuret), demonstrating that it was as active as the full-length protein. However, unlike full-length AtzF, AtzF467 was shown to be dimeric by (∼110 kDa; data not shown), suggesting that the C-terminal 14 kDa fragment may play a role in organizing the oligomeric state of AtzF. Thermal melting analysis showed that AtzF467 had a slightly higher Tm (50°C) than AtzF (Fig. 3).
The C-terminally truncated AtzF (AtzFThe AtzF467 construct produced large single crystals that were suitable for X-ray analysis in the presence of Tacsimate at pH 5 when seeded crystals were obtained from the Tascimate-containing PEG/Ion screen. The crystals were of variable quality, despite looking similar, and tens of crystals were tested before finding one [grown in 11%(w/v) PEG 3350, 2% Tacsimate pH 5] that diffracted isotropically to 2.5 Å resolution, which was used for data collection (Fig. 4). The crystals adopted P21, with unit-cell parameters a = 82.4, b = 179.2, c = 112.6 Å, β = 106.6°. In total, 86 96-well crystallization plates were set up to obtain the final well diffracting crystal.
While this manuscript was in preparation, the Kluyveromyces lactis was published (Fan et al., 2013). A comparison will be made between the published structure and that of AtzF in the near future.
of a full-length allophante hydrolase from the ureolytic yeastFootnotes
‡These authors contributed to this work equally.
Acknowledgements
We thank the beamline scientists of the Australian Synchrotron, and the CSIRO Collaborative Crystallization Centre (https://www.csiro.au/C3 ), Melbourne, Australia.
References
Bergmeyer, H. U. (1990). Editor. Methods of Enzymatic Analysis, 3rd ed. Weinheim: VCH. Google Scholar
Blakeley, R. L., Hinds, J. A., Kunze, H. E., Webb, E. C. & Zerner, B. (1969). Biochemistry, 8, 1991–2000. CrossRef CAS PubMed Web of Science Google Scholar
Carter, E. L., Flugga, N., Boer, J. L., Mulrooney, S. B. & Hausinger, R. P. (2009). Metallomics, 1, 207–221. Web of Science CrossRef CAS PubMed Google Scholar
Evans, P. (2006). Acta Cryst. D62, 72–82. Web of Science CrossRef CAS IUCr Journals Google Scholar
Fan, C., Li, Z., Yin, H. & Xiang, S. (2013). J. Biol. Chem. 288, 21422–21432. Web of Science CrossRef CAS PubMed Google Scholar
Kabsch, W. (2010). Acta Cryst. D66, 125–132. Web of Science CrossRef CAS IUCr Journals Google Scholar
Kanamori, T., Kanou, N., Atomi, H. & Imanaka, T. (2004). J. Bacteriol. 186, 2532–2539. Web of Science CrossRef PubMed CAS Google Scholar
Maitz, G. S., Haas, E. M. & Castric, P. A. (1982). Biochem. Biophys. Acta, 714, 486–491. CrossRef CAS Web of Science Google Scholar
Martinez, B., Tomkins, J., Wackett, L. P., Wing, R. & Sadowsky, M. J. (2001). J. Bacteriol. 183, 5684–5697. Web of Science CrossRef PubMed CAS Google Scholar
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. & Read, R. J. (2007). J. Appl. Cryst. 40, 658–674. Web of Science CrossRef CAS IUCr Journals Google Scholar
Miller, J. H. (1972). Experiments in Molecular Genetics. New York: Cold Spring Harbor Laboratory Press. Google Scholar
Nakamura, A., Yao, M., Chimnaronk, S., Sakai, N. & Tanaka, I. (2006). Science, 312, 1954–1958. Web of Science CrossRef PubMed CAS Google Scholar
Newman, J., Egan, D., Walter, T. S., Meged, R., Berry, I., Ben Jelloul, M., Sussman, J. L., Stuart, D. I. & Perrakis, A. (2005). Acta Cryst. D61, 1426–1431. Web of Science CrossRef CAS IUCr Journals Google Scholar
Peat, T. S., Balotra, S., Wilding, M., French, N. G., Briggs, L. J., Panjikar, S., Cowieson, N., Newman, J. & Scott, C. (2013). Mol. Microbiol. 88, 1149–1163. Web of Science CrossRef CAS PubMed Google Scholar
Roon, R. J. & Levenberg, B. (1972). J. Biol. Chem. 247, 4107–4113. CAS PubMed Web of Science Google Scholar
Seabrook, S. A. & Newman, J. (2013). ACS Comb. Sci. 15, 387–392. Web of Science CrossRef CAS PubMed Google Scholar
Shapir, N., Cheng, G., Sadowsky, M. J. & Wackett, L. P. (2006). Appl. Environ. Microbiol. 72, 2491–2495. Web of Science CrossRef PubMed CAS Google Scholar
Shapir, N., Sadowsky, M. J. & Wackett, L. P. (2005). J. Bacteriol. 187, 3731–3738. Web of Science CrossRef PubMed CAS Google Scholar
Shapiro, A. L., Viñuela, E. & Maizel, J. V. (1967). Biochem. Biophys. Res. Commun. 28, 815–820. CrossRef CAS PubMed Web of Science Google Scholar
Shin, S., Lee, T.-H., Ha, N.-C., Koo, H. M., Kim, S., Lee, H.-S., Kim, Y. S. & Oh, B.-H. (2002). EMBO J. 21, 2509–2516. Web of Science CrossRef PubMed CAS Google Scholar
Strope, P. K., Nickerson, K. W., Harris, S. D. & Moriyama, E. N. (2011). BMC Evol. Biol. 11, 80. Google Scholar
Udiković-Kolić, N., Scott, C. & Martin-Laurent, F. (2012). Appl. Microbiol. Biotechnol. 96, 1175–1189. Web of Science PubMed Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.